0
     

Report Added
Report already added
Asia Pacific In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity

Asia Pacific In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity

Asia Pacific in vitro diagnostics (IVD) market will grow by 7.8% annually with a total addressable market cap of $303,673.6 million over 2022-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.
Highlighted with 35 tables and 64 figures, this 138-page report “Asia Pacific In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments & Devices
oDisposable IVD Devices
oReusable IVD Devices
•Reagents & Kits
•Software & Services

Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Clinical Chemistry
•Molecular Diagnostics
•Immuno Diagnostics
•Hematology
•Tissue Diagnostics
•Microbiology
•Coagulation and Hemostasis
•Urinalysis
•Other Technologies

By Sample Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Blood
•Mucus
•Urine
•Other Sample Types

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Infectious Diseases
•Diabetes
•Cancer/Oncology
•Cardiology
•Autoimmune Disease
•Nephrology
•Drug Testing
•HIV/AIDS
•Other Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Diagnostic Laboratories
•Hospitals and Clinics
•Homecare Settings
•Point-of-Care (POC) Settings
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Japan
•China
•South Korea
•Australia
•India
•Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy20
2.1.2 Impact of COVID-19 on the Market24
2.2 Major Growth Drivers26
2.3 Market Restraints and Challenges32
2.4 Emerging Opportunities and Market Trends35
2.5 Porter’s Fiver Forces Analysis39
3 Segmentation of Asia Pacific Market by Product43
3.1 Market Overview by Product43
3.2 Instruments & Devices45
3.2.1 Disposable IVD Devices46
3.2.2 Reusable IVD Devices47
3.3 Reagents & Kits48
3.4 Software & Services49
4 Segmentation of Asia Pacific Market by Technology50
4.1 Market Overview by Technology50
4.2 Clinical Chemistry52
4.3 Molecular Diagnostics53
4.4 Immuno Diagnostics54
4.5 Hematology55
4.6 Tissue Diagnostics56
4.7 Microbiology57
4.8 Coagulation and Hemostasis58
4.9 Urinalysis59
4.10 Other Technologies60
5 Segmentation of Asia Pacific Market by Sample Type61
5.1 Market Overview by Sample Type61
5.2 Blood63
5.3 Mucus64
5.4 Urine65
5.5 Other Sample Types66
6 Segmentation of Asia Pacific Market by Application67
6.1 Market Overview by Application67
6.2 Infectious Diseases69
6.3 Diabetes79
6.4 Cancer/Oncology80
6.5 Cardiology81
6.6 Autoimmune Disease82
6.7 Nephrology83
6.8 Drug Testing84
6.9 HIV/AIDS85
6.10 Other Applications86
7 Segmentation of Asia Pacific Market by End User87
7.1 Market Overview by End User87
7.2 Diagnostic Laboratories89
7.3 Hospitals and Clinics90
7.4 Homecare Settings91
7.5 Point-of-Care (POC) Settings92
7.6 Other End Users93
8 Asia-Pacific Market 2021-2031 by Country94
8.1 Overview of Asia-Pacific Market94
8.2 Japan97
8.3 China100
8.4 Australia102
8.5 India104
8.6 South Korea106
8.7 Rest of APAC Region108
9 Competitive Landscape110
9.1 Overview of Key Vendors110
9.2 New Product Launch, Partnership, Investment, and M&A113
9.3 Company Profiles114
Abbott Laboratories, Inc.114
Agilent Technologies, Inc.116
Arkray Inc.117
Becton, Dickinson and Company118
Biomerieux SA119
Bio-Rad Laboratories Inc.120
Danaher Corporation121
DiaSorin SpA (Luminex Corporation)122
Epic Systems Corporation123
F. Hoffmann-La Roche Ltd.124
Genpact Limited125
Grifols SA126
IBM Corporation127
Mckesson Corporation128
Ortho Clinical Diagnostics Inc.129
Qiagen NV130
Quest Diagnostics Inc.131
Quidel Corporation132
Roche Diagnostics133
Siemens Healthineers134
Sysmex Corporation135
Thermo Fisher Scientific Inc.136
RELATED REPORTS137List of Tables:

Table 1. Snapshot of Asia Pacific In Vitro Diagnostics Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203121
Table 3. World Economic Outlook, 2021-202322
Table 4. World Health Spending by Region, $ bn, 2013-202031
Table 5. Main Product Trends and Market Opportunities in Asia Pacific In Vitro Diagnostics Market35
Table 6. Asia Pacific In Vitro Diagnostics Market by Product, 2021-2031, $ mn43
Table 7. Asia Pacific In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn45
Table 8. Asia Pacific In Vitro Diagnostics Market by Technology, 2021-2031, $ mn50
Table 9. Asia Pacific In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn61
Table 10. Asia Pacific In Vitro Diagnostics Market by Application, 2021-2031, $ mn67
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-202270
Table 12. Asia Pacific In Vitro Diagnostics Market by End User, 2021-2031, $ mn87
Table 13. APAC In Vitro Diagnostics Market by Country, 2021-2031, $ mn95
Table 14. Japan In Vitro Diagnostics Market by Product, 2021-2031, $ mn99
Table 15. Japan In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn99
Table 16. Japan In Vitro Diagnostics Market by End User, 2021-2031, $ mn99
Table 17. China In Vitro Diagnostics Market by Product, 2021-2031, $ mn101
Table 18. China In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn101
Table 19. China In Vitro Diagnostics Market by End User, 2021-2031, $ mn101
Table 20. Australia In Vitro Diagnostics Market by Product, 2021-2031, $ mn103
Table 21. Australia In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn103
Table 22. Australia In Vitro Diagnostics Market by End User, 2021-2031, $ mn103
Table 23. India In Vitro Diagnostics Market by Product, 2021-2031, $ mn105
Table 24. India In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn105
Table 25. India In Vitro Diagnostics Market by End User, 2021-2031, $ mn105
Table 26. South Korea In Vitro Diagnostics Market by Product, 2021-2031, $ mn107
Table 27. South Korea In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn107
Table 28. South Korea In Vitro Diagnostics Market by End User, 2021-2031, $ mn107
Table 29. In Vitro Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn109
Table 30. Abbott Laboratories, Inc.: Company Snapshot114
Table 31. Abbott Laboratories, Inc.: Business Segmentation115
Table 32. Abbott Laboratories, Inc.: Product Portfolio115

Report Title: Asia Pacific In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW